Multiple, disparate roles for calcium signaling in apoptosis of human prostate and cervical cancer cells exposed to diindolylmethane

Molecular Cancer Therapeutics

Volumn 5, Issue 3, 2006, Pages 556-563

  Savino III, John A ^a   Evans, Jodi F ^a   Rabinowitz, Dorianne ^a   Auborn, Karen J ^b,c   Carter, Timothy H ^a,b,c  

^a ST JOHN'S UNIVERSITY   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; ADENOSINE TRIPHOSPHATASE; CALCIMYCIN; CALCIUM; CELECOXIB; CYCLOSPORIN A; DIINDOLYLMETHANE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FURA 2; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; RUTHENIUM RED; THAPSIGARGIN; TUNICAMYCIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CANCER CELL; CANCER INHIBITION; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CONTROLLED STUDY; CRUCIFERA; CYTOTOXICITY; ENDOPLASMIC RETICULUM; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NUCLEOSOME; PRIORITY JOURNAL; PROSTATE CANCER; SARCOPLASMIC RETICULUM; TARGET CELL; UTERINE CERVIX CANCER;

APOPTOSIS; BENZYLAMINES; CALCIUM; CALCIUM SIGNALING; CHELATING AGENTS; CYCLOSPORINE; CYTOSOL; EGTAZIC ACID; ENDOPLASMIC RETICULUM; ENZYME INHIBITORS; FEMALE; HUMANS; INDOLES; MALE; PROSTATIC NEOPLASMS; SULFONAMIDES; THAPSIGARGIN; UTERINE CERVICAL NEOPLASMS;

EID: 33645468792     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-05-0355     Document Type: Article

References (48)

1. Jin L, Qi M, Chen DZ, et al. Indole-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic mice. Cancer Res 1999;59:3991-7.
2. Bell MC, Crowley-Nowick P, Bradlow HL, et al. Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol 2000;78: 123-9.
3. Zhang X, Malejka-Giganti D. Effects of treatment of rats with indole-3-carbinol on apoptosis in the mammary gland and mammary adenocarcinomas. Anticancer Res 2003;23:2473-9.
4. Nachshon-Kedmi M, Fares FA, Yannai S. Therapeutic activity of 3,3′-diindolylmethane on prostate cancer in an in vivo model. Prostate 2004; 61:153-60.
5. Chang X, Tou JC, Hong C, et al. 3,3′-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. Carcinogenesis 2005;26:771-8.
6. Auborn KJ. Therapy for recurrent respiratory papillomatosis. Antivir Ther 2002;7:1-9.
7. Auborn KJ, Qi M, Yan XJ, et al. Life span is prolonged in autoimmuneprone (NZB/NZW) F1 mice fed a diet supplemented with indole-3-carbinol. J Nutr 2003;133:3610-3.
8. Anderton MJ, Manson MM, Verschoyle RD, et al. Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice. Clin Cancer Res 2004;10: 5233-41.
9. Ge X, Yannai S, Rennert G, Gruener N, Fares FA. 3,3′-Diindolylmethane induces apoptosis in human cancer cells. Biochem Biophys Res Commun 1996;228:153-8.
10. Ge X, Fares FA, Yannai S. Induction of apoptosis in MCF-7 cells by indole-3-carbinol is independent of p53 and bax. Anticancer Res 1999;19: 3199-203.
11. Chen DZ, Qi M, Auborn KJ, Carter TH. Indole-3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic preneoplastic cervical epithelium. J Nutr 2001; 131:3294-302.
12. Bonnesen C, Eggleston IM, Hayes JD. Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res 2001;61:6120-30.
13. Nachshon-Kedmi M, Yannai S, Haj A, Fares FA. Indole-3-carbinol and 3,3′diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem Toxicol 2003;41:745-52.
14. Carter TH, Liu K, Ralph W, Jr., et al. Diindolylmethane alters gene expression in human keratinocytes in vitro. J Nutr 2002;132:3314-24.
15. Lee SH, Kim JS, Yamaguchi K, Eling TE, Baek SJ. Indole-3-carbinol and 3,3′diindolylmethane induce expression of NAG-1 in a p53-independent manner. Biochem Biophys Res Commun 2005; 328:63-9.
16. Li Y, Li X, Sarkar FH. Gene expression profiles of I3C- and DIM-treated PC3 human prostate cancer cells determined by cDNA microarray analysis. J Nutr 2003;133:1011-9.
17. Chang YC, Riby J, Chang GH, Peng BC, Firestone G, Bjeldanes LF. Cytostatic and antiestrogenic effects of 2-(indol-3-ylmethyl)-3,3′-diindolylmethane, a major in vivo product of dietary indole-3-carbinol. Biochem Pharmacol 1999;58:825-34.
18. Leong H, Firestone GL, Bjeldanes LF. Cytostatic effects of 3,3′-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-α expression. Carcinogenesis 2001;22:1809-17.
19. Hong C, Kim HA, Firestone GL, Bjeldanes LF. 3,3′-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis 2002;23:1297-305.
20. Firestone GL, Bjeldanes LF. Indole-3-carbinol and 3-3′-diindolylmethane antiproliferative signaling pathways control cell-cycle gene transcription in human breast cancer cells by regulating promoter-Sp1 transcription factor interactions. J Nutr 2003;133 Suppl:S2448-55.
21. Jellinck PH, Forkert PG, Riddick DS, Okay AB, Michnovicz JJ, Bradlow HL. Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem Pharmacol 1993; 45:1129-36.
22. Takahashi N, Dashwood RH, Bjeldanes LF, Bailey GS, Williams DE. Regulation of hepatic cytochrome P4501A by indole-3-carbinol: transient induction with continuous feeding in rainbow trout. Food Chem Toxicol 1995;33:111-20.
23. Chen I, Safe S, Bjeldanes L. Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells. Biochem Pharmacol 1996;51:1069-76.
24. Chen I, McDougal A, Wang F, Safe S. Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 1998;19:1631-9.
25. Chintharlapalli S, Smith R III, Samudio I, Zhang W, Safe S. 1,1-Bis(3′-indolyl)-1-(p substituted phenyl)methanes induce peroxisome proliferator-activated receptor γ-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells. Cancer Res 2004;64: 5994-6001.
26. Meng Q, Yuan F, Goldberg ID, Rosen EM, Auborn K, Fan S. Indole-3-carbinol is a negative regulator of estrogen receptor-α signaling in human tumor cells. J Nutr 2000;130:2927-31.
27. Yuan F, Chen DZ, Liu K, Sepkovic DW, Bradlow HL, Auborn K. Anti-estrogenic activities of indole-3-carbinol in cervical cells: implication for prevention of cervical cancer. Anticancer Res 1999;19:1673-80.
28. Shilling AD, Carlson DB, Katchamart S, Williams DE. 3,3′-Diindolylmethane, a major condensation product of indole-3-carbinol, is a potent estrogen in the rainbow trout. Toxicol Appl Pharmacol 2001;170:191-200.
29. Auborn KJ, Fan S, Rosen EM, et al. Indole-3-carbinol is a negative regulator of estrogen. J Nutr 2003;133 Suppl:S2470-5.
30. Le HT, Schaldach CM, Firestone GL, Bjeldanes LF. Plant-derived 3,3′-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells. J Biol Chem 2003;278:21136-45.
31. Sun S, Han J, Ralph WM, Jr., et al. Endoplasmic reticulum stress as a correlate of cytotoxicity in human tumor cells exposed to diindolylmethane in vitro. Cell Stress Chaperones 2004;9:76-87.
32. Xue L, Firestone GL, Bjeldanes LF. DIM stimulates IFNγ gene expression in human breast cancer cells via the specific activation of JNK and p38 pathways. Oncogene 2005;24:2343-53.
33. Howells LM, Gallacher-Horley B, Houghton CE, Manson MM, Hudson EA. Indole-3-carbinol inhibits protein kinase B/Akt and induces apoptosis in the human breast tumor cell line MDA MB468 but not in the nontumorigenic HBL100 line. Mol Cancer Ther 2002;1:1161-72.
34. Rahman KM, Li Y, Sarkar FH. Inactivation of akt and NF-κB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells. Nutr Cancer 2004;48:84-94.
35. Rahman KW, Sarkar FH. Inhibition of nuclear translocation of nuclear factor-κB contributes to 3,3′-diindolylmethane-induced apoptosis in breast cancer cells. Cancer Res 2005;65:364-71.
36. Hong C, Firestone GL, Bjeldanes LF. Bcl-2 family-mediated apoptotic effects of 3,3′-diindolylmethane (DIM) in human breast cancer cells. Biochem Pharmacol 2002;63:1085-97.
37. Nachshon-Kedmi M, Yannai S, Fares FA. Induction of apoptosis in human prostate cancer cell line, PC3, by 3,3′-diindolylmethane through the mitochondrial pathway. Br J Cancer 2004;91:1358-63.
38. Schroder M, Kaufman RJ. ER stress and the unfolded protein response. Mutat Res 2005;569:29-63.
39. Booth C, Koch GL. Perturbation of cellular calcium induces secretion of luminal ER proteins. Cell 1989;59:729-37.
40. Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol 2000;2:326-32.
41. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-50.
42. Jan CR, Ho CM, Wu SN, Tseng CJ. The phospholipase C inhibitor U73122 increases cytosolic calcium in MDCK cells by activating calcium influx and releasing stored calcium. Life Sci 1998;63:895-908.
43. 2+ transport by ruthenium red. Biochem Biophys Res Commun 1971;42:298-305.
44. Wertz IE, Dixit VM. Characterization of calcium release-activated apoptosis of LNCaP prostate cancer cells. J Biol Chem 2000;275: 11470-7.
45. 2+ movement and cell proliferation in human osteoblasts. Biochem Pharmacol 2004;67:1123-30.
46. Berridge MJ, Bootman MD, Roderick HL. Calcium signaling: dynamics, homeostasis and remodeling. Nat Rev Mol Cell Biol 2003;4:517-29.
47. Rao RV, Ellerby HM, Bredesen DE. Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ 2004;11:372-80.
48. 2+ homeostasis in apoptotic resistance of prostate cancer cells. Biochem Biophys Res Commun 2004; 322:1326-35.